Literature DB >> 20074070

Genotype-phenotype correlations in laminopathies: how does fate translate?

Juergen Scharner1, Viola F Gnocchi, Juliet A Ellis, Peter S Zammit.   

Abstract

A-type laminopathies are a group of diseases resulting from mutations in the intermediate filament proteins lamin A and C (both encoded by the LMNA gene), but for which the pathogenic mechanisms are little understood. In some laminopathies, there is a good correlation between the presence of a specific LMNA mutation and the disease diagnosed. In others however, many different mutations can give rise to the same clinical condition, even though the mutations may be distributed throughout one, or more, of the three functionally distinct protein domains of lamin A/C. Conversely, certain mutations can cause multiple laminopathies, with related patients carrying an identical mutation even having separate diseases, often affecting different tissues. Therefore clarifying genotype-phenotype links may provide important insights into both disease penetrance and mechanism. In the present paper, we review recent developments in genotype-phenotype correlations in laminopathies and discuss the factors that could influence pathology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20074070     DOI: 10.1042/BST0380257

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  21 in total

1.  Aging genetics and aging.

Authors:  Sandra Rodríguez-Rodero; Juan Luis Fernández-Morera; Edelmiro Menéndez-Torre; Vincenzo Calvanese; Agustín F Fernández; Mario F Fraga
Journal:  Aging Dis       Date:  2011-04-28       Impact factor: 6.745

Review 2.  Nuclear mechanics in disease.

Authors:  Monika Zwerger; Chin Yee Ho; Jan Lammerding
Journal:  Annu Rev Biomed Eng       Date:  2011-08-15       Impact factor: 9.590

3.  The nuclear envelope: LINCing tissue mechanics to genome regulation in cardiac and skeletal muscle.

Authors:  Rachel Piccus; Daniel Brayson
Journal:  Biol Lett       Date:  2020-07-08       Impact factor: 3.703

4.  Biomechanical defects and rescue of cardiomyocytes expressing pathologic nuclear lamins.

Authors:  Erik Laurini; Valentina Martinelli; Thomas Lanzicher; Luca Puzzi; Daniele Borin; Suet Nee Chen; Carlin S Long; Patrice Lee; Luisa Mestroni; Matthew R G Taylor; Orfeo Sbaizero; Sabrina Pricl
Journal:  Cardiovasc Res       Date:  2018-05-01       Impact factor: 10.787

Review 5.  Beyond membrane channelopathies: alternative mechanisms underlying complex human disease.

Authors:  Konstantinos Dean Boudoulas; Peter J Mohler
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

6.  Deleterious assembly of the lamin A/C mutant p.S143P causes ER stress in familial dilated cardiomyopathy.

Authors:  Gun West; Josef Gullmets; Laura Virtanen; Song-Ping Li; Anni Keinänen; Takeshi Shimi; Monika Mauermann; Tiina Heliö; Maija Kaartinen; Laura Ollila; Johanna Kuusisto; John E Eriksson; Robert D Goldman; Harald Herrmann; Pekka Taimen
Journal:  J Cell Sci       Date:  2016-05-27       Impact factor: 5.285

7.  Molecular characterization of an allelic series of mutations in the mouse Nox3 gene.

Authors:  John P Flaherty; Heather E Fairfield; Catrina A Spruce; Christopher M McCarty; David E Bergstrom
Journal:  Mamm Genome       Date:  2010-12-15       Impact factor: 2.957

8.  A novel homozygous p.Arg527Leu LMNA mutation in two unrelated Egyptian families causes overlapping mandibuloacral dysplasia and progeria syndrome.

Authors:  Mohammad Al-Haggar; Agnieszka Madej-Pilarczyk; Lukasz Kozlowski; Janusz M Bujnicki; Sohier Yahia; Dina Abdel-Hadi; Amany Shams; Nermin Ahmad; Sahar Hamed; Monika Puzianowska-Kuznicka
Journal:  Eur J Hum Genet       Date:  2012-05-02       Impact factor: 4.246

9.  Genotype-phenotype analysis of LMNA-related diseases predicts phenotype-selective alterations in lamin phosphorylation.

Authors:  Eric W Lin; Graham F Brady; Raymond Kwan; Alexey I Nesvizhskii; M Bishr Omary
Journal:  FASEB J       Date:  2020-05-15       Impact factor: 5.191

10.  Ameliorating pathogenesis by removing an exon containing a missense mutation: a potential exon-skipping therapy for laminopathies.

Authors:  J Scharner; N Figeac; J A Ellis; P S Zammit
Journal:  Gene Ther       Date:  2015-04-02       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.